Langerhans Cell Histiocytosis (LCH)

Histiocytic disorders are a group of rare disorders characterised by the abnormal accumulation of histiocytes, a type of immune cell often found in tissues that regulates immune functions. There are three primary types of histiocytes, including monocytes (plays a role in inflammatory and anti-inflammatory responses during an immune response), macrophages (responsible for ingesting and eliminating foreign substances during an immune reaction), and dendritic cells (initiate and regulate the adaptive immune response).

Histiocytic disorders are broadly classified into five different groups: L groupC groupM groupR group, and H group. The L group, or Langerhans group, are classified as diseases involving Langerhans cells (an immune cell responsible for initiating an immune response when coming into contact with a foreign material), such as Langerhans cell histiocytosis (LCH). The C group, also known as cutaneous and mucocutaneous non-Langerhans cell histiocytosis, are classified as non-Langerhans cell histiocytic disorders that are localised to the skin or mucosal surfaces, such as the mouth, nose, and gastrointestinal system. The M group, also known as malignant histiocytic disorders, are classified by the presence of malignant cells within the tumour(s). The R group, also known as Rosai-Dorfman disease and miscellaneous non-cutaneous non-Langerhans cell histiocytosis or sinus histiocytosis, are classified as non-Langerhans histiocytic disorders that often involve lymph nodes. The H group, also known as hemophagocytic lymphocytosis and macrophage activation syndrome, is composed entirely of hemophagocytic lymphohistiocytosis, a rare and aggressive disease caused by the overactivation of the immune system.

This page will focus on Langerhans cell histiocytosis (LCH), a common subtype of L group histiocytic disorders. It is defined as a rare cancer-like disease that causes excess production of a certain type of dendritic immune cell, known as Langerhans cells. These cells are most commonly found in the skin, but can also be found in the bone/bone marrow, lymph nodes and thymus, eyes, endocrine organs, central nervous system, liver, and spleen, and/or lungs.

LCH is more common in boys, and is generally diagnosed in children (especially children under the age of 5). However, anyone can develop this disease.

Types of Langerhans Cell Histiocytosis

There are various types of LCH, which can be classified by the number of bodily systems affected.

Single-System LCH

Single-system LCH is the most common form of LCH, and occurs when the disease is only present in one organ or system of the body. It is most commonly found in children between the ages of five and ten, and is generally discovered as a bone lesion. Single-system LCH can be aggressive, however it can have an excellent prognosis.

Multi-System LCH

Multi-system LCH is a less common form of LCH, and occurs when the disease is present in two or more organs or bodily systems. It is most commonly found in children under three years old or in adults. Multi-system LCH can be aggressive, and may not have as good of a prognosis as single-system LCH.

Eosinophillic Granuloma

Eosinophilic granuloma is the most common form LCH that generally appears as a benign bone lesion. It is most commonly found in the skull, but can also be found in the mandible (jaw), spine, ribs, long bones and less commonly the skin. In most cases, eosinophilic granuloma is found as a single lesion, will require little to no treatment and generally has a good prognosis. In rare instances, multiple bones or organ systems may be involved requiring more extensive treatment.

Hand-Schüller-Christian Disease

Hand-Schüller-Christian disease is an intermediate form of LCH that generally affects multiple areas of one organ system (often including the bone). It is often associated with a triad of diabetes insipidus (a rare disorder where the body produces too much urine), proptosis, and bone lesions (most commonly in the skull). Hand-Schüller-Christian has a varying level of aggressiveness and prognosis depending on how many organs and lesions are involved.

Letterer-Siwe Disease

Letterer-Siwe disease is a rare form of LCH that generally affects many organ systems of the body. It is most commonly diagnosed before the age of three, and most commonly affects the lungs, bones, liver and lymph nodes. Letterer-Siwe disease is often very aggressive, and may not have as good of a prognosis as other types of LCH.

Treatment

Each patient with LCH will present with a unique disease behaviour, with varying locations, and symptoms. As such, there is no one treatment method that will work for everyone, and there is no standard staging system for this disease. Generally, the treatment of LCH is based upon whether it is single or multi-system LCH, and which organs/systems are, or could potentially be, affected.

Your doctor may recommend genetic testing, which analyses your tumour DNA and can help determine which treatment has the greatest chance of success. Your doctor will discuss the most appropriate course of treatment for you.

Treatment options for patients with LCH may include:

  • Surgery, potentially including:
    • Tumour excision.
    • Curettage.
    • Organ transplant.
  • Radiation therapy.
  • Cryotherapy.
  • Photodynamic therapy.
  • Immunotherapy.
  • Targeted therapy.
  • Watch and wait.
  • Clinical trials.
  • Palliative care.

Some of the information regarding treatment was obtained from the Langerhans Cell Histiocytosis Treatment (PDQ) page published by the National Cancer Institute.

Risk factors

While the exact cause of LCH remains unknown, the following factors may increase the likelihood of developing this disease:

  • Having a parent who was exposed to:
    • Certain solvents.
    • Metal, granite and/or wood dust in the workplace.
  • Having a family history of cancer or LCH.
  • Having previously been diagnosed with a thyroid disease.
  • Having a family history of thyroid disease.
  • Having had infections as a newborn.
  • Smoking.
  • Being unvaccinated as a child.
  • Being Hispanic.
  • Having mutations of BRAF, MAP2K1, RAS and/or ARAF genes.

Not everyone with these risk factors will develop the disease, and some people who have the disease may have none of these risk factors. See your general practitioner (GP) if you are concerned.

Some of the information regarding risk factors was obtained from the Langerhans Cell Histiocytosis Treatment (PDQ) page published by the National Cancer Institute.

Symptoms

The symptoms of LCH will vary depending on the location(s) of the disease.

General LCH symptoms

General symptoms of LCH that may occur in patients with the disease in any location include:

  • Fever.
  • Unexplained sweating.
  • Unexplained weight loss.
  • Small pink or reddish-brown lesions.

LCH affecting the bone and/or bone marrow

Some patients with LCH may appear asymptomatic. Symptoms of LCH affecting the bone include:

  • Localised bone pain.
  • Swelling or a lump over a bone.

If the patient has LCH in the bone marrow, some of these symptoms may also appear:

  • Easy bruising and/or bleeding.
  • Fever.
  • Frequent and/or recurrent infections.

LCH affecting the skin and nails

The symptoms of LCH in the skin and/or nails will vary between infants and children/adults.

Infants

In infants, LCH usually appears on the skin, but not the nails. Some of these symptoms include:

  • Flaking of the scalp. This may resemble the condition ‘cradle cap’.
  • Flaking in creases of the skin, such as the armpit, inner elbow or perineum (area between the genitals and anus).
  • Skin rash that may appear anywhere on the body:
    • Raised.
    • Brown or purple in colour.

Children and adults

The symptoms of LCH of the nails and skin in adults may include:

  • Flaking of the scalp. This may resemble dandruff.
  • Skin rash that may appear:
    • Raised.
    • Brown or purple in colour.
    • Crusty.
    • Itchy and/or painful.
    • Occurring on the abdomen, pelvic region back and/or chest.
  • Ulcers and/or bumps on the scalp, behind the ears, under the breasts or in the pelvic region.
  • Fingernails that have fallen off or appear discoloured.

LCH affecting the mouth

Symptoms of LCH in patients with the disease in their mouth may present with some of the following symptoms:

  • Swollen gums.
  • Sores that may appear on the roof of the mouth, inside of the cheeks, on the tongue or on the lips.
  • Dental issues, such as teeth falling out or becoming uneven.

LCH affecting the lymph nodes and/or the thymus

Patients with LCH in the lymph nodes or thymus may present with some of the following symptoms:

  • Lymphadenopathy.
  • Persistent cough.
  • Changes in breathing, such as accelerated breathing or dyspnea.
  • Superior vena cava syndrome, which has its own set of symptoms:
    • Coughing.
    • Dyspnea.
    • Swelling of the face, neck and/or upper arms.

LCH affecting the endocrine system.

The endocrine system is the network of organs and glands in the body that is responsible for the production of hormones. Symptoms of LCH in the pituitary gland of the endocrine system may include:

  • Diabetes insipidus, which causes polydipsia and polyuria.
  • Growth/developmental delay.
  • Early or late puberty.
  • Obesity.

Symptoms of LCH in the thyroid gland of the endocrine system may include:

  • Swollen thyroid gland.
  • Hypothyroidism, which has varying symptoms between infants, children/adolescents and adults.
  • Dyspnea.

LCH affecting the eye

The most common symptom of LCH affecting the eye is vision changes, such as difficulties seeing, blurriness and/or blindness.

LCH affecting the central nervous system (CNS).

The central nervous system (CNS) is responsible for all sensory and motor functions in the body, and is composed of the brain and spinal cord. Symptoms of LCH in the CNS may include:

  • Changes in balance and coordination.
  • Difficulty walking.
  • Difficulties with speaking and/or seeing.
  • Diplopia.
  • Headaches.
  • Changes in behaviour and/or personality.
  • Memory difficulties.
  • Altered mental status.

LCH affecting the liver, spleen and/or abdomen

Symptoms of LCH affecting the liver, spleen and/or abdomen may include:

  • Abdominal pain and/or swelling.
  • Diarrhoea.
  • Unexplained weight loss.
  • Jaundice.
  • General itchiness.
  • Easy bruising and/or bleeding.
  • Fatigue

LCH affecting the lungs

Symptoms of LCH affecting the lungs may include:

  • Collapsed lung, which carries its own set of symptoms:
    • Chest pains and/or tightness.
    • Dyspnea.
    • Fatigue.
    • Skin turning a bluish colour due to a lack of oxygen.
  • Persistent dry cough.
  • Chest pain

Not everyone with the symptoms above will have cancer, but see GP if you are concerned.

Some of the information regarding symptoms was obtained from the Langerhans Cell Histiocytosis Treatment (PDQ) page published by the National Cancer Institute.

Diagnosis

If your doctor suspects you have LCH, they may order the following tests to confirm the diagnosis and refer you to a specialist for treatment:

  • Physical examination.
  • Neurological examination.
  • Blood tests.
  • Urine tests.
  • Imaging tests, potentially including:
    • MRI (magnetic resonance imaging).
    • CT (computed tomography) scan.
    • PET (positron emission tomography) scan.
    • Ultrasound.
    • X-ray.
    • Bone scan.
  • Pulmonary function test.
  • Exploratory surgery, potentially including:
    • Endoscopy.
    • Bronchoscopy.
  • Bone marrow aspiration.
  • Biopsy.

References

Keep up with Rare Cancers Australia

Inside Rare is a monthly newsletter that shares the latest news, events and stories connecting the rare community.